GlassScriptPhysician profile
Joshua Hamann
NPI 1881709715
$56,791.42
in general payments reported to CMS, 2019-2025
14 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,571 · 2020: $3,210 · 2021: $1,474 · 2022: $8,572 · 2023: $12K · 2024: $579 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $4,015 · Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,375.00 |
| Travel and Lodging | $4,015.00 |
| Food and Beverage | $1,374.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $51,270.91 | 2019-2025 | |
| Elite Orthopedics, LLC | $4,783.32 | 2019-2025 | |
| Smith+Nephew, INC. | $194.52 | 2019-2025 | Journey II, Tandem |
| Zimmer Biomet Holdings, INC. | $112.65 | 2021-2023 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $107.02 | 2019-2021 | |
| Depuy Synthes Sales INC. | $86.43 | 2019-2024 | Monovisc |
| Organogenesis INC. | $51.63 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $48.83 | 2025 | |
| Sanofi-Aventis U.S. LLC | $47.58 | 2019-2021 | |
| Kerecis Limited | $22.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bone Support INC. | $19.46 | 2022 | |
| Hospira, INC. | $17.62 | 2024 | |
| Cardinal Health 200 LLC | $17.35 | 2019 | |
| Fidia Pharma USA INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Hamann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.